Joseph P. McEvoy, MD | Psychiatrist.com

Original Research

The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia: 2003 Update

April 1, 2004

Alexander L. Miller, Catherine S. Hall, Robert W. Buchanan, et al

Original Research

Prolactin Levels in Schizophrenia and Schizoaffective Disorder Patients Treated With Clozapine, Olanzapine, Risperidone, or Haloperidol

January 1, 2004

Jan Volavka, Pal Czobor, Thomas B. Cooper, et al

Original Research

Olanzapine in Refractory Schizophrenia After Failure of Typical or Atypical Antipsychotic Treatment: An Open-Label Switch Study

October 1, 2002

Jean-Pierre Lindenmayer, Pal Czobor, Jan Volavka, et al

Original Research

Safety and Tolerability of Oral Loading Divalproex Sodium in Acutely Manic Bipolar Patients

December 31, 1999

Robert M. A. Hirschfeld, Michael H. Allen, Joseph P. McEvoy, et al

Academic Highlights

Atypical Antipsychotic Agents in the Treatment of Schizophrenia and Other Psychiatric Disorders. Part II: Special Considerations

June 15, 1998

Stephen R. Marder, Dilip V. Jeste, Joseph P. McEvoy

Academic Highlights

Atypical Antipsychotic Agents in the Treatment of Schizophrenia and Other Psychiatric Disorders. Part I: Unique Patient Populations

May 15, 1998

Stephen R. Marder, Dilip V. Jeste, Joseph P. McEvoy

Article

Introduction/New Treatment Options to Improve Clinical Outcomes

January 1, 1998

Joseph P. McEvoy

Letter to the Editor

Reply to Letter to the Editor "Guideline Series Commentary"

October 15, 1997

David A. Kahn, John P. Docherty, Allen Frances, et al

« 1 2 3